These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

555 related items for PubMed ID: 17667922

  • 41. [Experimental study on the effect of trichostatin A on differentiation of human lung carcinoma cell].
    Wang CT, Meng M.
    Zhonghua Yi Xue Za Zhi; 2007 Apr 03; 87(13):927-9. PubMed ID: 17650409
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Curcumin-induced histone hypoacetylation: the role of reactive oxygen species.
    Kang J, Chen J, Shi Y, Jia J, Zhang Y.
    Biochem Pharmacol; 2005 Apr 15; 69(8):1205-13. PubMed ID: 15794941
    [Abstract] [Full Text] [Related]

  • 46. Trichostatin A induces morphological changes and gelsolin expression by inhibiting histone deacetylase in human carcinoma cell lines.
    Hoshikawa Y, Kwon HJ, Yoshida M, Horinouchi S, Beppu T.
    Exp Cell Res; 1994 Sep 15; 214(1):189-97. PubMed ID: 8082721
    [Abstract] [Full Text] [Related]

  • 47. Inhibitors of DNA methylation and histone deacetylation activate cytomegalovirus promoter-controlled reporter gene expression in human glioblastoma cell line U87.
    Grassi G, Maccaroni P, Meyer R, Kaiser H, D'Ambrosio E, Pascale E, Grassi M, Kuhn A, Di Nardo P, Kandolf R, Küpper JH.
    Carcinogenesis; 2003 Oct 15; 24(10):1625-35. PubMed ID: 12869421
    [Abstract] [Full Text] [Related]

  • 48. Involvement of extracellular signal-regulated kinase activation in human osteosarcoma cell resistance to the histone deacetylase inhibitor FK228 [(1S,4S,7Z,10S,16E,21R)-7-ethylidene-4,21-bis(propan-2-yl)-2-oxa-12,13-dithia-5,8,20,23-tetraazabicyclo[8.7.6]tricos-16-ene-3,6,9,19,22-pentone].
    Matsubara H, Watanabe M, Imai T, Yui Y, Mizushima Y, Hiraumi Y, Kamitsuji Y, Watanabe K, Nishijo K, Toguchida J, Nakahata T, Adachi S.
    J Pharmacol Exp Ther; 2009 Mar 15; 328(3):839-48. PubMed ID: 19073909
    [Abstract] [Full Text] [Related]

  • 49. Histone deacetylase inhibitors increase human arylamine N-acetyltransferase-1 expression in human tumor cells.
    Paterson S, Sin KL, Tiang JM, Minchin RF, Butcher NJ.
    Drug Metab Dispos; 2011 Jan 15; 39(1):77-82. PubMed ID: 20870783
    [Abstract] [Full Text] [Related]

  • 50. Attenuation of c-Jun and Sp1 expression and p300 recruitment to gene promoter confers the trichostatin A-induced inhibition of 12(S)-lipoxygenase expression in EGF-treated A431 cells.
    Chen CJ, Chang WC, Chen BK.
    Eur J Pharmacol; 2008 Sep 04; 591(1-3):36-42. PubMed ID: 18590721
    [Abstract] [Full Text] [Related]

  • 51. The temporal relationship between ABCB1 promoter hypomethylation, ABCB1 expression and acquisition of drug resistance.
    Reed K, Hembruff SL, Sprowl JA, Parissenti AM.
    Pharmacogenomics J; 2010 Dec 04; 10(6):489-504. PubMed ID: 20125118
    [Abstract] [Full Text] [Related]

  • 52. Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer.
    Zhong S, Fields CR, Su N, Pan YX, Robertson KD.
    Oncogene; 2007 Apr 19; 26(18):2621-34. PubMed ID: 17043644
    [Abstract] [Full Text] [Related]

  • 53. Inhibition of histone deacetylation by butyrate induces morphological changes in Y79 retinoblastoma cells.
    Karasawa Y, Okisaka S.
    Jpn J Ophthalmol; 2004 Apr 19; 48(6):542-51. PubMed ID: 15592778
    [Abstract] [Full Text] [Related]

  • 54. The zinc finger repressor, ZBP-89, recruits histone deacetylase 1 to repress vimentin gene expression.
    Wu Y, Zhang X, Salmon M, Zehner ZE.
    Genes Cells; 2007 Aug 19; 12(8):905-18. PubMed ID: 17663720
    [Abstract] [Full Text] [Related]

  • 55. Modulation of the cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene by Zac1 through the antagonistic regulators p53 and histone deacetylase 1 in HeLa Cells.
    Liu PY, Chan JY, Lin HC, Wang SL, Liu ST, Ho CL, Chang LC, Huang SM.
    Mol Cancer Res; 2008 Jul 19; 6(7):1204-14. PubMed ID: 18644983
    [Abstract] [Full Text] [Related]

  • 56. Effects of histone deacetylase inhibitors on the Ah receptor gene promoter.
    Garrison PM, Rogers JM, Brackney WR, Denison MS.
    Arch Biochem Biophys; 2000 Feb 15; 374(2):161-71. PubMed ID: 10666294
    [Abstract] [Full Text] [Related]

  • 57. Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor: effects on gene expression and growth of glioma cells in vitro and in vivo.
    Yin D, Ong JM, Hu J, Desmond JC, Kawamata N, Konda BM, Black KL, Koeffler HP.
    Clin Cancer Res; 2007 Feb 01; 13(3):1045-52. PubMed ID: 17289901
    [Abstract] [Full Text] [Related]

  • 58. Chemoresistance to depsipeptide FK228 [(E)-(1S,4S,10S,21R)-7-[(Z)-ethylidene]-4,21-diisopropyl-2-oxa-12,13-dithia-5,8,20,23-tetraazabicyclo[8,7,6]-tricos-16-ene-3,6,9,22-pentanone] is mediated by reversible MDR1 induction in human cancer cell lines.
    Xiao JJ, Huang Y, Dai Z, Sadée W, Chen J, Liu S, Marcucci G, Byrd J, Covey JM, Wright J, Grever M, Chan KK.
    J Pharmacol Exp Ther; 2005 Jul 01; 314(1):467-75. PubMed ID: 15833893
    [Abstract] [Full Text] [Related]

  • 59. TSA-induced DNMT1 down-regulation represses hTERT expression via recruiting CTCF into demethylated core promoter region of hTERT in HCT116.
    Choi JH, Min NY, Park J, Kim JH, Park SH, Ko YJ, Kang Y, Moon YJ, Rhee S, Ham SW, Park AJ, Lee KH.
    Biochem Biophys Res Commun; 2010 Jan 01; 391(1):449-54. PubMed ID: 19914212
    [Abstract] [Full Text] [Related]

  • 60. The effects of trichostatin A on the oncolytic ability of herpes simplex virus for oral squamous cell carcinoma cells.
    Katsura T, Iwai S, Ota Y, Shimizu H, Ikuta K, Yura Y.
    Cancer Gene Ther; 2009 Mar 01; 16(3):237-45. PubMed ID: 18949013
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 28.